Maxime Dely: Behind Every Machine, There Is a Human Story
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“Behind every machine, there is a human story.
Today, I cared for a patient undergoing a lymphocyte collection as part of the preparation for CAR-T cell therapy, an innovative treatment for a specific large B-cell lymphoma.
At first, he was understandably intimidated by the machine.
Watching your blood circulate through an extracorporeal circuit can be unsettling.
We took the time to talk about all sorts of things, while I explained how the procedure and the technology worked.
As the conversation went on, something struck me: the way he spoke, his expressions, even his appearance… he reminded me so much of my grandfather, who passed away years ago.
People often say that our job is about operating machines, medical devices, and advanced technologies.
And that’s true.
But behind every procedure is, above all, a person with fears, a story, and hope.
Connecting a patient to a machine is never just a technical act.
Technical expertise is essential, but so are empathy, trust, and human connection.”

Other posts featuring Maxime Dely on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines